Zibotentan
- Generic Name
- Zibotentan
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H16N6O4S
- CAS Number
- 186497-07-4
- Unique Ingredient Identifier
- 8054MM4902
- Indication
Investigated for use/treatment in prostate cancer.
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Investigate the Blood Concentrations of 4 Different Oral Doses of Zibotentan in Healthy Non-Asian and Japanese Participants
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 20
- Registration Number
- NCT06715670
- Locations
- 🇺🇸
Research Site, Glendale, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath